Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-25

Clinical Trial Update: A Phase 1 Study to Evaluate PK Profile and Food Effects on PK Parameters of TNP-2092 Capsules [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the pharmacokinetic profile of TNP-2092 capsules and the effect of food on PK in hyperammonemia; the study has completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNP-2092

Snippet

Sponsor: TenNor Therapeutics (Suzhou) Limited | Conditions: Hyperammonemia | Phase 1 | Status: COMPLETED | Results posted: 2025-04-25